Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Biotech ETF (XBI)

65.52
Delayed Data
As of 7:59pm ET
 -2.28 / -3.36%
Today’s Change
44.16
Today|||52-Week Range
73.80
-6.67%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Performance

1 month+11.04% 3 years+16.54%
3 months+30.18% 5 years+28.06%
1 year+8.70% Since inception+14.59%
Data through 09/29/2016

Quote Details

Previous close$67.80
Open day’s range65.26 – 67.80
Net asset value (NAV)67.80 (09/28/2016)
Daily volume8,225,132
Average volume (3 months)6,899,443
Data as of 7:59pm ET, 09/29/2016

Peer Comparisonvs. Health ETFs

 XBICategory
Performance 5-yr return+28.06%+15.32%
Expense Gross exp ratio0.35%0.48%
Risk 5 year sharpe ratio0.871.16
Net assets$2.1B$1.1B
Average market cap$4.6B$37.2B
Average P/E--20.2
Dividend / Share--0.22%

Competitors

XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim Invest S&P 500 Eql Wght Healt...
VHT Vanguard Health Care Index Fund ETF Shar...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
IONS Ionis Pharmaceuticals Inc3.09%
-- 3.04%
SRPT Sarepta Therapeutics Inc2.96%
BIIB Biogen2.81%
BMRN Biomarin Pharmaceutical Inc2.62%
ALNY Alnylam Pharmaceuticals Inc2.50%
AMGN Amgen2.49%
UTHR United Therapeutics Corp2.49%
TSRO TESARO Inc2.48%
BLUE bluebird bio Inc2.47%